The findings indicated a reduction in the fluorescence area fraction and mean fluorescence intensity of LOX and LOXL2 in the tumour region of individuals showing sensitivity to neoadjuvant chemotherapy compared to those exhibiting resistance, although statistical significance was not achieved (Figure 5F). Here, LOXL2 is linked to neoplasm.